
The Cooper Companies, Inc. - COO
COO (The Cooper Companies, Inc.) is available as a tokenized stock from 1 issuer across 10 blockchains.
The Cooper Companies, Inc. is a global medical device company focused on eyecare and women’s health, headquartered in San Ramon, California. The business operates through two main segments: CooperVision and CooperSurgical. CooperVision develops, manufactures, and markets a broad portfolio of contact lenses, including spherical, toric, and multifocal designs that address conditions such as myopia, hyperopia, astigmatism, and presbyopia, as well as products aimed at managing ocular dryness and eye fatigue. Its branded lens families, such as Proclear, Biofinity, MyDay, and Clariti, serve eye-care professionals and contact lens wearers worldwide and position the company as a major participant in the soft contact lens market. CooperSurgical provides medical devices, equipment, and consumables for fertility, in vitro fertilization (IVF), and women’s health, supporting clinical workflows across the reproductive care continuum. Within this segment, the company offers products used in assisted reproductive technology, obstetrics, gynecology, and long-acting reversible contraception, making it a notable supplier to hospitals, clinics, and specialty practices focused on women, babies, and family health.
Chart data are delayed by 15 minutes.
Upcoming
No dividend is currently scheduled.
History(41)
| Ex-date | Amount |
|---|---|
| Jul 26, 2023 | $0.0075 USD |
| Jan 20, 2023 | $0.0075 USD |
| Jul 26, 2022 | $0.0075 USD |
| Jan 20, 2022 | $0.0075 USD |
| Jul 26, 2021 | $0.0075 USD |
| Jan 21, 2021 | $0.0075 USD |
| Jul 22, 2020 | $0.0075 USD |
| Jan 22, 2020 | $0.0075 USD |
| Jul 22, 2019 | $0.0075 USD |
| Jan 18, 2019 | $0.0075 USD |
Page 1 of 5 · 41 results
Upcoming
No corporate event is currently scheduled.
History(3)
| Type | Effective | Detail |
|---|---|---|
| Stock split | Feb 20, 2024 | 4-for-11 share → 4 shares |
| Stock split | Nov 25, 2002 | 2-for-11 share → 2 shares |
| Reverse split | Sep 22, 1995 | 1-for-33 shares → 1 share |
Page 1 of 1 · 3 results





